Parexel Introduces Expert Series – New Medicines, Novel Insights
28 févr. 2023 09h00 HE
|
Parexel International LLC
DURHAM, N.C., Feb. 28, 2023 (GLOBE NEWSWIRE) -- Parexel, one of the world’s largest clinical research organizations (CROs) providing the full range of Phase I to IV clinical development services,...
Parexel Teams with MyEyeDr. to Increase Patient Access and Participation in Ophthalmology Clinical Trials
15 déc. 2022 09h00 HE
|
Parexel International LLC
BOSTON and DURHAM, N.C., Dec. 15, 2022 (GLOBE NEWSWIRE) -- Parexel, one of the world’s largest clinical research organizations (CROs) providing the full range of Phase I to IV clinical development...
Parexel Announces Significant Recognition for Diversity and Workplace Culture in Asia/Pacific Region; Reaches Significant Company Milestone in Japan
29 nov. 2022 09h00 HE
|
Parexel International LLC
BOSTON and DURHAM, N.C., Nov. 29, 2022 (GLOBE NEWSWIRE) -- Parexel, one of the world’s largest clinical research organizations (CROs) providing the full range of Phase I to IV clinical development...
Parexel Opens Clinical Trial Supplies and Logistics Depot in Suzhou, China
27 sept. 2022 16h30 HE
|
Parexel International LLC
New depot offers local and international biopharmaceutical customers timely access to supplies and medications for clinical trial sites and patientsto accelerate clinical trials in the region BOSTON...
Parexel’s Peyton Howell Awarded Prestigious PharmaVoice Red Jacket
15 sept. 2022 16h00 HE
|
Parexel International LLC
BOSTON and DURHAM, N.C., Sept. 15, 2022 (GLOBE NEWSWIRE) -- Parexel, a leading global clinical research organization (CRO) focused on development and delivery of innovative new therapies to advance...
Parexel Appoints Peyton Howell Chief Operating and Growth Officer; Promotes FDA Veteran Amy McKee, MD, to Chief Medical Officer and Global Head, Oncology Center of Excellence
14 sept. 2022 09h00 HE
|
Parexel International LLC
BOSTON and DURHAM, N.C., Sept. 14, 2022 (GLOBE NEWSWIRE) -- Parexel, a leading global clinical research organization (CRO), today announced the promotions of Peyton Howell to the newly-created role...
Parexel Expands Network of Global Regulatory Experts
08 sept. 2022 09h00 HE
|
Parexel International LLC
BOSTON and DURHAM, N.C., Sept. 08, 2022 (GLOBE NEWSWIRE) -- Parexel, a leading global clinical research organization (CRO) focused on development and delivery of innovative new therapies to advance...
Parexel’s Jim Anthony Named to 2022 PharmaVOICE 100
07 sept. 2022 10h23 HE
|
Parexel International LLC
BOSTON and DURHAM, N.C., Sept. 07, 2022 (GLOBE NEWSWIRE) -- Parexel, a leading global clinical research organization (CRO) focused on development and delivery of innovative new therapies to advance...
Parexel Expands Patient Access to Clinical Trials Through New Community Alliance Network
16 juin 2022 09h09 HE
|
Parexel International LLC
BOSTON, and Durham, N.C., June 16, 2022 (GLOBE NEWSWIRE) -- Parexel, a leading global clinical research organization (CRO), today announced the launch of its Community Alliance Network, a novel...
Parexel Named 2022 Catalyst Award Winner
19 janv. 2022 09h00 HE
|
Parexel International LLC
BOSTON, and DURHAM, N.C., Jan. 19, 2022 (GLOBE NEWSWIRE) -- Parexel, a leading global clinical research organization (CRO) focused on development and delivery of innovative new therapies to advance...